Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
211.80
+7.90 (3.87%)
At close: Aug 22, 2025, 4:00 PM
211.60
-0.20 (-0.09%)
After-hours: Aug 22, 2025, 7:36 PM EDT

Danaher Operating Metrics

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
Recurring Revenue
19.80B19.52B19.50B17.04B17.44B18.09B18.68B19.17B
Recurring Revenue Growth
13.52%7.90%4.37%-11.11%-11.95%-11.16%-10.51%-18.76%
Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Diagnostics
9.76B9.71B9.79B9.87B9.76B9.73B9.58B9.83B
Diagnostics Growth
0.01%-0.20%2.19%0.41%-4.82%-8.06%-11.72%-8.72%
Life Sciences
7.27B7.26B7.33B7.23B7.15B7.18B7.14B7.16B
Life Sciences Growth
1.68%1.21%2.63%0.98%-22.50%-37.03%-47.38%-54.33%
Biotechnology
6.98B6.85B6.76B6.65B6.66B6.83B7.17B7.64B-----------
Biotechnology Growth
4.86%0.22%-5.76%-12.93%---------------
Environmental and Applied Solutions
-------4.95B4.91B4.88B4.83B4.81B4.75B4.68B4.65B
Environmental and Applied Solutions Growth
-------2.76%3.20%4.38%3.81%4.61%5.04%7.00%8.04%
Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Diagnostics
2.51B2.51B2.63B2.77B2.69B2.56B2.41B2.63B
Diagnostics Growth
-6.69%-1.80%9.10%5.25%-5.61%-20.70%-29.98%-21.29%
Biotechnology
1.87B1.74B1.63B1.53B1.56B1.64B1.91B2.19B-----------
Biotechnology Growth
19.87%6.29%-14.88%-29.87%---------------
Environmental
-------1.19B1.19B1.20B1.14B1.06B1.03B1.01B1.05B
Environmental Growth
-------12.34%15.60%19.20%7.69%-2.84%-4.62%-1.86%7.66%
Life Sciences
373.00M845.00M879.00M738.00M1.02B1.12B1.21B1.37B
Life Sciences Growth
-63.29%-24.76%-27.30%-45.97%-51.57%-61.70%-67.58%-69.19%
Other
-337.00M-334.00M-326.00M-323.00M-358.00M-392.00M-413.00M-417.00M
Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
North America
10.25B10.25B10.30B10.11B10.71B11.20B11.59B12.68B--
North America Growth
-4.30%-8.55%-11.20%-20.23%-18.75%-17.84%-17.00%-6.91%--
High Growth Markets
6.87B6.87B6.87B6.88B7.23B7.73B8.28B8.74B--
High Growth Markets Growth
-5.03%-11.17%-17.03%-21.28%-19.12%-14.85%-9.26%-5.49%--
Western Europe
5.66B5.48B5.46B5.31B5.58B5.96B6.35B6.73B--
Western Europe Growth
1.53%-8.17%-14.04%-21.16%-18.06%-12.16%-8.13%-2.73%--
Other Developed Markets
1.23B1.23B1.25B1.27B1.30B1.33B1.38B1.41B--
Other Developed Markets Growth
-5.03%-7.68%-9.21%-10.53%-8.99%-7.76%-5.92%-3.15%--
Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019
Selling, General, and Administrative
8.30B7.81B7.76B7.77B7.86B8.18B8.52B8.68B
Selling, General, and Administrative Growth
5.66%-4.53%-8.94%-10.43%-9.49%-4.55%0.06%0.65%
Research and Development
1.61B1.60B1.58B1.55B1.58B1.61B1.67B1.72B
Research and Development Growth
1.52%-0.93%-5.21%-9.78%-7.97%-7.10%-4.24%-3.92%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.